Certara (CERT) vs Sprinklr (CXM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Sprinklr (CXM) has outperformed Certara (CERT) over the past year, losing 29.1% versus a loss of 33.5%. Over five years, CXM leads with a -69.5% price change compared with -77.2% for CERT. Certara is the larger company by market cap ($1.32 billion vs $1.26 billion), about 1.0 times the size.
On valuation, Sprinklr trades at a lower forward P/E (10.1x vs 22.2x for Certara).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CERT | CXM |
|---|---|---|
| Share price | $8.64 | $5.42 |
| Market cap | $1.32B | $1.26B |
| 1-day change | -3.57% | +4.43% |
| YTD return | -1.93% | -30.33% |
| 1-year return | -33.54% | -29.06% |
| 5-year return | -77.17% | -69.52% |
| P/E ratio (TTM) | — | 60.22 |
| Forward P/E | 22.17 | 10.14 |
| EPS (TTM) | $-0.13 | $0.09 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $13.11 | $8.28 |
| 52-week low | $4.45 | $4.72 |
| Distance from 52-week high | -34.10% | -34.50% |
| Analyst consensus | buy | none |
| Avg. price target upside | +0.81% | +55.72% |
| Average volume | 3.10M | 3.33M |
| Shares outstanding | 152.54M | 131.09M |
| Employees | 1,515 | 3,258 |
| Sector | Healthcare | Technology |
| Industry | Health Information Services | Computer Software: Prepackaged Software |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Certara in Healthcare and Sprinklr in Technology.
About Certara
CERT stock →Certara, Inc., together with its subsidiaries, provides technology-driven services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the Americas, Europe, the Middle East, Africa, and Asia Pacific. It offers model-informed drug development solutions; biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scientists working on pre-investigational new drug and translational stages; Simcyp Biopharmaceutics for formulation scientists; and Simcyp Secondary Intelligence that integrates toxicology with quantitative analysis of large networks of molecular and functional biological changes.
Healthcare · Health Information Services · 1,515 employees
About Sprinklr
CXM stock →Sprinklr, Inc. provides enterprise cloud software products worldwide.
Technology · Computer Software: Prepackaged Software · 3,258 employees
CERT vs CXM FAQ
Which is bigger, Certara or Sprinklr?
Certara (CERT) is larger, with a market capitalization of $1.32B compared with $1.26B for Sprinklr (CXM).
Which stock has performed better over the past year, CERT or CXM?
CXM returned -29.06% over the past 12 months, compared with -33.54% for CERT (price return, excluding dividends). Past performance does not predict future results.
Are Certara and Sprinklr in the same industry?
No. Certara is in the Healthcare sector, while Sprinklr is in Technology.